Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment

被引:17
作者
Zhang, Mengjun [1 ]
Jiang, Huiyang [1 ]
Wu, Lan [1 ]
Lu, Haoyu [1 ]
Bera, Hriday [1 ,2 ]
Zhao, Xing [1 ]
Guo, Xiong [1 ]
Liu, Xulu [1 ]
Cun, Dongmei [1 ]
Yang, Mingshi [1 ,3 ]
机构
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Wenhua Rd, 103, Shenyang 110016, Peoples R China
[2] Dr BC Roy Coll Pharm & Allied Hlth Sci, Durgapur 713212, West Bengal, India
[3] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Univ Pk 2, DK-2100 Copenhagen, Denmark
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
Pulmonary delivery; siRNA; Lipid nanoparticles; Asthma; Airway epithelial cells; THYMIC STROMAL LYMPHOPOIETIN; IN-VIVO; ICAM-1; EXPRESSION; GENE DELIVERY; PULMONARY; INFLAMMATION; MACROPHAGES; RECEPTOR; MUCUS; RESPONSES;
D O I
10.1016/j.jconrel.2022.10.020
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
With specific and inherent mRNA cleaving activity, small interfering RNA (siRNA) has been deemed promising therapeutics to reduce the exacerbation rate of asthma by inhibiting the expression and release of proin-flammatory cytokines from airway epithelial cells (AECs). To exert the therapeutic effects of siRNA drugs, nano -formulations with high efficiency and safety are required to deliver these nucleic acids to the target cells. Herein, we exploited novel inhaled lipid nanoparticles (LNPs) targeting intercellular adhesion molecule-1 (ICAM-1) receptors on the apical side of AECs. This delivery system is meant to enhance the specific delivery efficiency of siRNA in AECs to prevent the expression of proinflammatory cytokines in AECs and the concomitant symptoms in parallel. A cyclic peptide that resembles part of the capsid protein of rhinovirus and binds to ICAM-1 receptors was initially conjugated with cholesterol and subsequently assembled with ionizable cationic lipids to form the LNPs (Pep-LNPs) loaded with siRNA against thymic stromal lymphopoietin (TSLP siRNA). The obtained Pep-LNPs were subjected to thorough characterization and evaluations in vitro and in vivo. Pep-LNPs significantly enhanced cellular uptake and gene silencing efficiency in human epithelial cells expressing ICAM-1 in vitro, exhibited AEC-specific delivery and improved the gene silencing effect in ovalbumin-challenged asthmatic mice after pulmonary administration. More importantly, Pep-LNPs remarkably downregulated the expression of TSLP in AECs, effectively alleviated inflammatory cell infiltration, and reduced the secretion of other proinflammatory cytokines, including IL-4 and IL-13, as well as mucus production in asthmatic mice. This study demonstrates that Pep-LNPs are safe and efficient to deliver siRNA drugs to asthmatic AECs and could potentially alleviate allergic asthma by inhibiting the overexpression of proinflammatory cytokines in the airway.
引用
收藏
页码:422 / 437
页数:16
相关论文
共 50 条
  • [1] Lipid nanoparticles for siRNA delivery in cancer treatment
    Moukhtari, Souhaila H. El
    Garbayo, Elisa
    Amundarain, Ane
    Pascual-Gil, Simon
    Carrasco-Leon, Arantxa
    Prosper, Felipe
    Agirre, Xabier
    Blanco-Prieto, Maria J.
    JOURNAL OF CONTROLLED RELEASE, 2023, 361 : 130 - 146
  • [2] CELL-SPECIFIC SIRNA DELIVERY BY PEPTIDES AND ANTIBODIES
    Lee, Sang-Kyung
    Siefert, Alyssa
    Beloor, Jagadish
    Fahmy, Tarek M.
    Kumar, Priti
    METHODS IN ENZYMOLOGY, VOL 502: PROTEIN ENGINEERING FOR THERAPEUTICS, PT A, 2012, 502 : 91 - 122
  • [3] Delivery of siRNA Using Lipid Nanoparticles Modified with Cell Penetrating Peptide
    Li, Yuhuan
    Lee, Robert J.
    Yu, Kongtong
    Bi, Ye
    Qi, Yuhang
    Sun, Yating
    Li, Yujing
    Xie, Jing
    Teng, Lesheng
    ACS APPLIED MATERIALS & INTERFACES, 2016, 8 (40) : 26613 - 26621
  • [4] Lipid Nanoparticles for Cell-Specific in Vivo Targeted Delivery of Nucleic Acids
    Khalil, Ikramy A.
    Younis, Mahmoud A.
    Kimura, Seigo
    Harashima, Hideyoshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (04) : 584 - 595
  • [5] Targeted siRNA delivery to lung epithelia reduces airway inflammation in a mouse model of allergic asthma
    Ullah, Irfan
    Choi, Hyo Sung
    Choi, Changseon
    Chung, Kunho
    Jung, Jae Wook
    Yun, Gyeongju
    Heo, Seoyoun
    Yi, Yujong
    Kang, Eunhwa
    Kim, Sang-Heon
    Yoon, Ho Joo
    Rhim, Taiyoun
    Lee, Sang-Kyung
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2024, 29 (01) : 97 - 108
  • [6] Role of airway epithelial cell miRNAs in asthma
    Boateng, Eistine
    Kovacevic, Draginja
    Oldenburg, Vladimira
    Radinger, Madeleine
    Krauss-Etschmann, Susanne
    FRONTIERS IN ALLERGY, 2022, 3
  • [7] Recent advances in siRNA delivery mediated by lipid-based nanoparticles
    Yonezawa, Sei
    Koide, Hiroyuki
    Asai, Tomohiro
    ADVANCED DRUG DELIVERY REVIEWS, 2020, 154 : 64 - 78
  • [8] Airway epithelial cell-specific deletion of HMGB1 exaggerates inflammatory responses in mice with muco-obstructive airway disease
    Mao, Yun
    Patial, Sonika
    Saini, Yogesh
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [9] Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes
    Kim, Sun Hwa
    Lee, Soo Hyeon
    Tian, Huayu
    Chen, Xuesi
    Park, Tae Gwan
    JOURNAL OF DRUG TARGETING, 2009, 17 (04) : 311 - 317
  • [10] Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier
    d'Angelo, Ivana
    Costabile, Gabriella
    Durantie, Estelle
    Brocca, Paola
    Rondelli, Valeria
    Russo, Annapina
    Russo, Giulia
    Miro, Agnese
    Quaglia, Fabiana
    Petri-Fink, Alke
    Rothen-Rutishauser, Barbara
    Ungaro, Francesca
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2018, 31 (03) : 170 - 181